Design, Synthesis, and Anticancer Activity of Amide Derivatives of Structurally Modified Combretastatin-A4


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A new series of amide derivatives of structurally modified combretastatin-A4 10a–10j are synthesized, and their structures are confirmed by 1H and 13C NMR, and mass spectral data. The products are tested for their anticancer activity towards human cancer cell lines, MCF-7 (breast), A-549 (lung), Colo-205 (colon), and A-2780 (ovarian). The compounds 10b, 10c, and 10d demonstrate the most promising activity.

About the authors

V. Ragha Suma

Department of Chemistry, GITAM Institute of Science; Department of Chemistry

Email: rammohanrao.k@gmail.com
India, Rushikonda, Visakhapatnam, Andhra Pradesh, 530045; Bhadrachalam, Telangana, 507111

R. Sreenivasulu

Department of Chemistry, University College of Engineering (Autonomous)

Email: rammohanrao.k@gmail.com
India, Kakinada, Andhra Pradesh, 533003

M. Subramanyam

Department of Chemistry

Email: rammohanrao.k@gmail.com
India, Khammam, Telangana, 507002

K. Ram Mohan Rao

Department of Chemistry, GITAM Institute of Technology

Author for correspondence.
Email: rammohanrao.k@gmail.com
India, Rushikonda, Visakhapatnam, Andhra Pradesh, 530045


Copyright (c) 2019 Pleiades Publishing, Ltd.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies